QNTM
Quantum BioPharma Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.24
+9.83%Institutional positioning
13F filings over the trailing two quarters
New 7Increased 7Reduced 2Sold out 25
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ADVISORSHARES INVESTMENTS LLC | Increased | 108,591 | Apr 28, 2026 |
| PLATFORM TECHNOLOGY PARTNERS | New Position | 41,116 | Apr 27, 2026 |
| JANE STREET GROUP, LLC | Increased | 31,501 | May 12, 2026 |
| CITADEL ADVISORS LLC | Unchanged | 15,863 | May 15, 2026 |
| CITADEL ADVISORS LLC | Unchanged | 15,863 | Sep 2, 2026 |
| MAREX GROUP PLC | Increased | 13,468 | May 13, 2026 |
| VIRTU FINANCIAL LLC | Increased | 12,282 | May 14, 2026 |
| MARINER, LLC | New Position | 10,059 | May 13, 2026 |
| UBS GROUP AG | Increased | 7,237 | May 5, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | Increased | 6,375 | May 15, 2026 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | Unchanged | 4,381 | May 8, 2026 |
| ATLANTIC UNION BANKSHARES CORP | Unchanged | 1,000 | May 12, 2026 |
| FARTHER FINANCE ADVISORS, LLC | Unchanged | 1,000 | Apr 7, 2026 |
| JONES FINANCIAL COMPANIES LLLP | New Position | 700 | May 15, 2026 |
| CETERA TRUST COMPANY, N.A | Unchanged | 250 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings